Auris Medical (EARS) Shares Quadruples on Positive Data of AM-301
The Bermuda-based clinical-stage firm reports strong results from its drug-free nasal spray AM-301. The nasal spray results show potential for AM-301 to alleviatethe risk of Sars-CoV-2 virus. The last month of 2020 brings good news for the clinical-stage company, Auris Medical Holding Ltd. (EARS). The company reported that it has achieved positive efficacy data from […]
Auris Medical (EARS) Shares Quadruples on Positive Data of AM-301 Read More »